Loading insider details...
Beta
Latest Form 4 (Aug 17, 2026): Sale of 42,666 ZVRA shares, $474.8K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 17, 2026 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Sale | 42,666 | $474.8K |
| Jun 23, 2026 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Exercise/Conversion | 66,667 | n/a |
| May 13, 2026 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Sale | 1,794 | $20.3K |
| Feb 2, 2026 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Exercise/Conversion | 11,333 | n/a |
| Jun 30, 2025 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Sale | 24,000 | $221.0K |
| Jun 24, 2025 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Exercise/Conversion | 66,666 | n/a |
| Feb 3, 2025 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Grant/Award | 68,000 | n/a |
| Jun 25, 2024 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Grant/Award | 200,000 | n/a |
| Feb 28, 2023 | Lyell Immunopharma, Inc. (LYEL) | Grant/Award | 245,000 | n/a |
| Oct 12, 2022 | Lyell Immunopharma, Inc. (LYEL) | Grant/Award | 715,000 | n/a |